242 related articles for article (PubMed ID: 30811489)
1. Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles.
Tumiotto C; Alves BM; Recordon-Pinson P; Jourdain M; Bellecave P; Guidicelli GL; Visentin J; Bonnet F; Hessamfar M; Neau D; Sanchez J; Brander C; Sajadi M; Eyzaguirre L; Soares EA; Routy JP; Soares MA; Fleury H
PLoS One; 2019; 14(2):e0212347. PubMed ID: 30811489
[TBL] [Abstract][Full Text] [Related]
2. Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA.
Tumiotto C; Riviere L; Bellecave P; Recordon-Pinson P; Vilain-Parce A; Guidicelli GL; Fleury H;
PLoS One; 2017; 12(9):e0185211. PubMed ID: 28934310
[TBL] [Abstract][Full Text] [Related]
3. ART-Treated Patients Exhibit an Adaptive Immune Response against the HFVAC Peptides, a Potential HIV-1 Therapeutic Vaccine (Provir/Latitude45 Study).
Fleury H; Caldato S; Recordon-Pinson P; Thebault P; Guidicelli GL; Hessamfar M; Morlat P; Bonnet F; Visentin J
Viruses; 2020 Nov; 12(11):. PubMed ID: 33167335
[TBL] [Abstract][Full Text] [Related]
4. Resistance mutations and CTL epitopes in archived HIV-1 DNA of patients on antiviral treatment: toward a new concept of vaccine.
Papuchon J; Pinson P; Lazaro E; Reigadas S; Guidicelli G; Taupin JL; Neau D; Fleury H;
PLoS One; 2013; 8(7):e69029. PubMed ID: 23874854
[TBL] [Abstract][Full Text] [Related]
5. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes.
Garcia-Bates TM; Palma ML; Anderko RR; Hsu DC; Ananworanich J; Korber BT; Gaiha GD; Phanuphak N; Thomas R; Tovanabutra S; Walker BD; Mellors JW; Piazza PA; Kroon E; Riddler SA; Michael NL; Rinaldo CR; Mailliard RB;
EBioMedicine; 2021 Jan; 63():103175. PubMed ID: 33450518
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of HIV-1 CTL epitopes recognized by HLA I alleles in HIV-infected individuals at times near primary infection: the Provir/Latitude45 study.
Papuchon J; Pinson P; Guidicelli GL; Bellecave P; Thomas R; LeBlanc R; Reigadas S; Taupin JL; Baril JG; Routy JP; Wainberg M; Fleury H;
PLoS One; 2014; 9(6):e100452. PubMed ID: 24964202
[TBL] [Abstract][Full Text] [Related]
8. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Vaccine Against HIV, Viral Variability, Cytotoxic T Lymphocyte Epitopes, and Genetics of Patients.
Fleury H; Tumiotto C; Bellecave P; Recordon-Pinson P
AIDS Res Hum Retroviruses; 2018 Jan; 34(1):27-30. PubMed ID: 28899104
[TBL] [Abstract][Full Text] [Related]
10. CD8
Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
Hossain MS; Tomiyama H; Inagawa T; Ida S; Oka S; Takiguchi M
AIDS Res Hum Retroviruses; 2003 Jun; 19(6):503-10. PubMed ID: 12882660
[TBL] [Abstract][Full Text] [Related]
12. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.
Brumme ZL; Brumme CJ; Carlson J; Streeck H; John M; Eichbaum Q; Block BL; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor J; Yuki Y; Carrington M; Allen TM; Mallal S; Altfeld M; Heckerman D; Walker BD
J Virol; 2008 Sep; 82(18):9216-27. PubMed ID: 18614631
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
[TBL] [Abstract][Full Text] [Related]
14. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
J Immunol; 2003 Nov; 171(10):5611-23. PubMed ID: 14607970
[TBL] [Abstract][Full Text] [Related]
15. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
[TBL] [Abstract][Full Text] [Related]
16. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa.
Masemola AM; Mashishi TN; Khoury G; Bredell H; Paximadis M; Mathebula T; Barkhan D; Puren A; Vardas E; Colvin M; Zijenah L; Katzenstein D; Musonda R; Allen S; Kumwenda N; Taha T; Gray G; McIntyre J; Karim SA; Sheppard HW; Gray CM;
J Immunol; 2004 Oct; 173(7):4607-17. PubMed ID: 15383595
[TBL] [Abstract][Full Text] [Related]
17. Presentation of available CTL epitopes that induction of cell-mediated immune response against HIV-1 Koran clade B strain using computational technology.
Park H; Chung YS; Yoon CH; Lee SH; Kim SS; Kang C; Choi BS
HIV Med; 2016 Jun; 17(6):460-6. PubMed ID: 26471354
[TBL] [Abstract][Full Text] [Related]
18. The antiviral efficacy of HIV-specific CD8⁺ T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate.
Ranasinghe SR; Kramer HB; Wright C; Kessler BM; di Gleria K; Zhang Y; Gillespie GM; Blais ME; Culshaw A; Pichulik T; Simmons A; Rowland-Jones SL; McMichael AJ; Dong T
PLoS Pathog; 2011 May; 7(5):e1001341. PubMed ID: 21589893
[TBL] [Abstract][Full Text] [Related]
19. Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.
Zou C; Murakoshi H; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674626
[TBL] [Abstract][Full Text] [Related]
20. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
Cardinaud S; Consiglieri G; Bouziat R; Urrutia A; Graff-Dubois S; Fourati S; Malet I; Guergnon J; Guihot A; Katlama C; Autran B; van Endert P; Lemonnier FA; Appay V; Schwartz O; Kloetzel PM; Moris A
PLoS Pathog; 2011 May; 7(5):e1002049. PubMed ID: 21589903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
